???global.info.a_carregar???
I earned my PhD in Molecular Pathology and Genetics in 2025 at the Institute for Biomedical Sciences Abel Salazar (ICBAS), University of Porto. My doctoral thesis, entitled “Drug Repurposing as a Strategy to Overcome Ovarian Cancer Chemoresistance,” explored innovative approaches to address chemoresistance in ovarian cancer, one of the leading causes of cancer-related deaths among women. During my PhD, I focused on repurposing existing drugs as a potential strategy to treat chemoresistant ovarian cancer, providing promising insights into alternative therapeutic approaches. I previously completed a Master’s degree in Oncology in 2019 at ICBAS, University of Porto, where I developed a strong foundation in cancer research, and a Bachelor’s degree in Biology in 2016 at the University of Aveiro. This academic progression laid the groundwork for my deep interest in understanding the molecular mechanisms underlying cancer biology, particularly ovarian cancer, and in exploring therapeutic strategies to improve patient outcomes. Currently, I am a research collaborator at the Toxicologic Pathology Research Laboratory, part of the Applied Biomolecular Sciences Unit (UCIBIO) at the University Institute of Health Sciences (IUCS), Advanced Polytechnic and University Cooperative (CESPU). In this role, I am involved in several key research initiatives aimed at advancing the understanding and treatment of ovarian cancer. My research has led to important contributions to the field of ovarian cancer, including: 1. Creation of ovarian cancer patient-derived cultures for drug sensitivity screening: I developed a robust biobank of patient-derived cultures obtained from ovarian cancer malignant ascites, enabling more accurate and personalized testing of potential therapeutic agents. These models have been pivotal in identifying new drug candidates for treating resistant forms of ovarian cancer. 2. Generation of chemoresistant high-grade serous carcinoma cell lines: I successfully generated two high-grade serous carcinoma cell lines with a double-chemoresistant phenotype to carboplatin and paclitaxel. These cell lines are essential tools for studying the molecular mechanisms underlying drug resistance and for testing new therapeutic strategies. 3. Identification of synergistic effects of combination therapies: I identified promising synergistic effects between conventional chemotherapy agents and drug repurposing candidates, supporting the development of combination therapies to overcome chemoresistance in ovarian cancer and opening new therapeutic avenues for patients with resistant tumors. 4. Immunohistochemical characterization of ovarian cancer malignant ascites and tissues: I conducted detailed immunohistochemical analyses of malignant ascites and tissue samples from ovarian cancer patients, providing valuable insights into molecular markers associated with disease progression and therapeutic response. I have authored 14 peer-reviewed scientific articles, contributing significantly to the scientific community’s understanding of ovarian cancer. I currently have an H-index of 8 (Scopus), reflecting the impact of my research. I have also contributed to two book chapters, broadening my academic and scientific outreach. Throughout my academic career, I have been actively involved in the scientific community, having participated in 31 national and international scientific events focused on ovarian cancer, chemoresistance, and drug development. I have also co-supervised four undergraduate theses, contributing to the training and mentorship of emerging scientists. My scientific contributions have been recognized with two prestigious awards and/or honors, and I have been actively involved in several competitive research projects.
Read full resume ↓
Identification

Personal identification

Full name
Mariana Oliveira Nunes
Date of birth
1992/01/04
Gender
Female

Citation names

  • Nunes, Mariana
  • Nunes, M

Author identifiers

Ciência ID
DC17-6C7C-5869
ORCID iD
0000-0002-4733-5778
Researcher Id
rid90383
Scopus Author Id
57217494194

Email addresses

  • marianaoliveiranunes1992@gmail.com (Personal)

Telephones

Telephone
  • 912109575 (Personal)

Addresses

  • Estrada Exterior da Circunvalação 8136 1ºesquerdo, 4200-163, Porto, Porto, Portugal (Personal)

Websites

  • linkedin.com/in/mariana-nunes-139a61188 (Social media)

Knowledge fields

  • Medical and Health Sciences - Basic Medicine
  • Natural sciences - Biological Sciences - Biology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Intermediate (B1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2020/11/01 - 2025/01/28
Concluded
 Patologia e Genética Molecular (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
 Aprovado por unamidade
2017/09 - 2019/09
Concluded
 Mestrado em Oncologia (Mestrado)
Major in Oncologia Laboratorial
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"First line drug testing in ovarian cancer cell lines manipulated for Mesothelin expression" (THESIS/DISSERTATION)
 18
2011/09 - 2016/06
Concluded
 Biologia (Licenciatura)
Universidade de Aveiro, Portugal
"Biochemical characterization of the interaction phytoprotectors/phytopathogens in grapevine" (THESIS/DISSERTATION)
 15
Affiliation

Science

Category
Host institution 		Employer
2020/11/01 - 2024/10/31 Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2019/11/01 - 2020/10/31 Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Projects

Contract

Designation Funders
2025/09/01 - 2026/08/31 Targeting Resistant Ovarian Cancer: High-Throughput Screening for Personalized Treatments
TARGET4OC-GI2-CESPU-2025
Researcher
Cooperativa de Ensino Superior Politécnico e Universitário CRL, Portugal
 Cooperativa de Ensino Superior Politécnico e Universitário CRL
Ongoing
2025 - 2026 Targeting mitotic regulators as a therapeutic strategy to overcome chemoresistance in cancer.
TargetMito_GI2-CESPU-2025
Researcher
Cooperativa de Ensino Superior Politécnico e Universitário CRL, Portugal
Ongoing
2024/04/22 - 2025/04/21 Exploring the effectiveness of pitavastatin to potentiate immunotherapy using ovarian cancer ascites immune-organoid cultures
ImmunoT4OC_GI2- CESPU-2023
Researcher
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal

Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
Ongoing
2020/11/01 - 2024/10/31 Drug Repurposing as a Strategy to Overcome Ovarian Cancer Chemoresistance
2020.04720.BD
PhD Student Fellow
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2022/09/01 - 2023/08/31 Ovarian Cancer Ascites-Derived Organoids as a Preclinical Platform to Predict Therapeutical Responses
OVCARTEST_GI2-CESPU_2022
Researcher
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal

Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
Cooperativa de Ensino Superior Politécnico e Universitário
Concluded
2022/09/01 - 2023/08/31 Overcoming Paclitaxel Resistance in Ovarian Cancer
upPTXovcar-GI2-CESPU-2022
Researcher
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal

Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
Cooperativa de Ensino Superior Politécnico e Universitário
Concluded
2019/11/01 - 2020/10/31 Bloqueio da interacção MUC16-mesotelina para inibir a metastização peritoneal do carcinoma do ovário
PTDC/MEC-ONC/29503/2017
Master Student Fellow
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Nunes, Mariana; Almeida-Nunes, Diana Luísa; Ricardo, Sara. "Cell Microarray: an approach to evaluate drug-induced alterations in protein expression". In Advancements in Cancer Research, 133-144. Exon Publications, 2023.
    10.36255/cell-microarray
  2. Nunes, Mariana; Ricardo, Sara. "Chemoresistance in ovarian cancer: the role of malignant ascites". In Ovarian Cancer, 27-42. Exon Publications, 2022.
    Published • 10.36255/exon-publications-ovarian-cancer-malignant-ascites
Conference poster
  1. Érica Oliveira; Cláudia Santos; Nunes, Mariana; Ricardo, Sara; Vaz, Josiana. "Construção de “Cell Microarrays” como Estratégia para Avaliar Alterações na Expressão de Proteínas Induzidas por tratamentos em Linhas Celulares de Cancro do Ovário". Paper presented in LiveWell Talks – Young Researchers and Exploratory Projects, 2025.
  2. Amaro, F.; Nunes, Mariana; Guedes de Pinho; Ricardo, Sara; Pinto, Joana. "Alteraçõeses metabólicas associadas à resistência ao paclitaxel no cancro do ovário". Paper presented in 7th Encontro Nacional de Jovens Investigadores em Oncologia (ENJIO), 2025.
  3. Amaro, F.; Nunes, Mariana; Guedes de Pinho; Ricardo, Sara; Pinto, Joana. "Key metabolic signatures of paclitaxel resistance in ovarian cancer revealed by metabolomics". Paper presented in EUROTOX 2025, 2025.
  4. Amaro, F.; Nunes, Mariana; Guedes de Pinho; Ricardo, Sara; Pinto, Joana. "Metabolic signatures of paclitaxel resistance in ovarian cancer revealed by metabolomics". Paper presented in UCIBIO Health Joint Meeting, 2025.
  5. Santos, Cláudia; Oliveira, Érica; Ally, Sofia; Nunes, Mariana; Resende, Albina; Ricardo, Sara. "Ivermectin decreases the expression of ALDH1 in Ovarian Cancer Cell Lines in combination with chemotherapy". Paper presented in IV 1H-TOXRUN INTERNATIONAL CONGRESS 2025 No Boundaries for Toxicology: One Health, One Society, One Planet EMPOWERING THE FUTURE GENERATIONS: THE SYNERGY OF SCIENCE, EDUCATION AND SOCIETY, 2025.
  6. Nunes, Mariana; Ricardo, Sara. "Repurposing Ivermectin to Enhance Chemotherapy’s Effectiveness in High-Grade Serous Carcinoma". Paper presented in EACR 2024 Congress: Innovative Cancer Science, 2024.
  7. Almeida-Nunes, Diana Luísa; Mendes-Frias, Ana; Nunes, Mariana; Ferreira, Verónica; Lobo, Cláudia; Monteiro, Paula; Abreu, Miguel Henriques; et al. "Presence of exhausted lymphocytes in the ascitic microenvironment of ovarian cancer patients: implications for immune dysfunction". Paper presented in VII iBiMED Symposium: Sharing Science, Inspiring Progress, 2024.
  8. Nunes, Mariana; Costa, João; Bartosch, Carla; Ricardo, Sara. "The Expression of mRNA LGR6 is Increased in Low-Grade Serous Carcinoma". Paper presented in XXX Porto Cancer Meeting: RNA Biology in Cancer, 2024.
  9. Queijo, Beatriz; Amaro, Filipa; Nunes, Mariana; Guedes de Pinho, Paula; Ricardo, Sara; Pinto, Joana. "Exploring the mechanisms of resistance in ovarian cancer: A metabolomic approach". Paper presented in 17th Meeting of Young Researchers of University of Porto (IJUP), 2024.
  10. Almeida-Nunes, Diana Luísa; Nunes, Mariana; Osorio, Hugo; Ferreira, Verónica; Lobo, Cláudia; Monteiro, Paula; Abreu, Miguel Henriques; et al. "Análise proteómica de ascites de pacientes com cancro do ovário reflete a modificação metabólica no microambiente tumoral durante a quimioterapia". Paper presented in 8º Curso Avançado de Ginecologia Oncológica, 2023.
  11. Nunes, Mariana; Almeida-Nunes, Diana Luísa; Costa, Anabela; Ricardo, Sara. "Cell microarray as a powerful tool to accelerate cancer research: focus on drug screening". Paper presented in II TOXRUN INTERNATIONAL CONGRESS 2023, 2023.
  12. Nunes, Mariana; Duarte, Diana; Vale, Nuno; Ricardo, Sara. "Synergism between carboplatin and repurposed drugs in chemoresistant high-grade serous carcinoma". Paper presented in EACR: The invisible phase of metastasis: Impact of dormancy, cancer cell plasticity and evolution of the niche during metastatic progression - Virtual Event, 2022.
  13. Nunes, Mariana; Almeida-Nunes, Diana Luísa; Abreu, Miguel Henriques; Bartosch, Carla; Ricardo, Sara. "Recycling the discarded ovarian cancer ascites to monitor therapy resistance". Paper presented in 23rd European Congress on Gynaecological Oncology, 2022.
  14. Nunes, Mariana; Duarte, Diana; Vale, Nuno; Ricardo, Sara. "Combining repurposing drugs with paclitaxel has a synergic effect in chemoresistant high-grade serous carcinoma". Paper presented in 5th ASPIC International Congress, 2022.
  15. Brandão, Catarina; Almeida-Nunes, Diana Luísa; Nunes, Mariana; Osório, Hugo; Ricardo, Sara. "Development of an in silico approach to identify key proteins involved in the peritoneal dissemination of ovarian cancer". Paper presented in VII Jornadas da Bioquímica, 2022.
  16. Nunes, Mariana; Brandão, Catarina; Ricardo, Sara. "Combining paclitaxel with repurposing drugs improve ovarian cancer management". Paper presented in I Congresso Internacional da TOXRUN/ V Congresso da Associação Portuguesa de Ciências Forenses/XIV Jornadas Científicas de Ciências do Instituto Universitário de Ciências da Saúde, 2022.
  17. Ferreira, Sílvia; Nunes, Mariana; Almeida-Nunes, Diana Luísa; Ricardo, Sara. "Phenotypic Evaluation of the Ovarian Tumor Cells Presents in Malignant Ascites". Paper presented in I Congresso Internacional da TOXRUN/ V Congresso da Associação Portuguesa de Ciências Forenses/XIV Jornadas Científicas de Ciências do Instituto Universitário de Ciências da Saúde, 2022.
  18. Nunes, Mariana; Ricardo, Sara. "Pitavastatin partially restore paclitaxel sensitivity in high-grade serous carcinoma cell lines". Paper presented in EACR Conference 2021: Goodbye Flat Biology: Next Generation Cancer Models, virtual event, worldwide., 2021.
  19. Coelho, Ricardo; Ricardo, Sara; Amaral, Ana Luísa; Huang, Yen-Lin; Nunes, Mariana; Jacob, Francis; David, Leonor. "Mesothelin-expressing ovarian cancer cells exhibit enhanced invasion and peritoneal dissemination". Paper presented in EACR-AACR-ASPIC Conference 2020: Tumor Microenvironment, 2020.
  20. Nunes, Mariana; Coelho, Ricardo; David, Leonor; Ricardo, Sara. "A mesotelina modula a quimioresistência à carboplatina em linhas celulares do cancro do ovário". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, 2019.
  21. Nunes, Mariana; Coelho, Ricardo; Portugal, Raquel; Costa, Antonia; Lopes, José Manuel; David, Leonor; Ricardo, Sara. "Reduced expression of MUC16 and MSLN in cells from ascitic fluid and ovarian cancer cell lines". Paper presented in 7th i3S Annual Meeting, 2018.
  22. Félix, Carina; Nunes, Mariana; Andolfi, Anna; DellaGreca, Marina; Basso, S; Salvatore, Maria M; Correia, António; Alves, Artur; Esteves, Ana Cristina. "The effect of temperature on the expression of extracellular enzymes of Lasiodiplodia theobromae". Paper presented in IV Encontro Nacional de Pós-Graduação em Ciências Biológicas, 2015.
  23. Nunes, Mariana; Félix, Carina; Meneses, Rodrigo; Correia, António; Alves, Artur; Esteves, Ana Cristina. "Effect of temperature on the plant pathogen Lasiodiplodia theobromae: enzyme and secondary metabolites production". Paper presented in XVII Congress of European Mycologists, 2015.
  24. Félix, Carina; Nunes, Mariana; Correia, António; Alves, Artur; Esteves, Ana Cristina. "How do phytopathogenic fungi behave under a climate change scenario?". Paper presented in RS. Research day, 2015.
Journal article
  1. Nélia Fonseca; Mariana Nunes; Patrícia M. A. Silva; Hassan Bousbaa; Sara Ricardo. "Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines". Biomedicines (2025): https://doi.org/10.3390/biomedicines13122852.
    10.3390/biomedicines13122852
  2. Amaro, Filipa; Nunes, Mariana; Guedes de Pinho, Paula; Ricardo, Sara; Pinto, Joana. "Paclitaxel resistance-associated metabolic events in ovarian cancer cells". Metabolomics 21 6 (2025): https://doi.org/10.1007/s11306-025-02342-z.
    10.1007/s11306-025-02342-z
  3. Nunes, Mariana; Ricardo, Sara. "Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures". Pharmaceuticals (2024): https://doi.org/10.3390/ph18010014.
    10.3390/ph18010014
  4. Almeida-Nunes, Diana Luisa; Silva, João Pedro Nunes; Nunes, Mariana; Silva, Patrícia M. A.; Silvestre, Ricardo; Dinis-Oliveira, Ricardo Jorge; Bousbaa, Hassan; Ricardo, Sara. "Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines". International Journal of Molecular Sciences (2024): https://doi.org/10.3390/ijms252211935.
    10.3390/ijms252211935
  5. Nunes, Mariana; Almeida-Nunes, Diana Luísa; Ferreira, Verónica; Lobo, Cláudia; Monteiro, Paula; Abreu, Miguel Henriques; Bartosch, Carla; Ricardo, Sara. "Que outra utilidade clínica poderão ter as ascites no carcinoma do ovário?". Revista Portuguesa de Oncologia 7 1-2 (2024):
  6. Nunes, Mariana; Bartosch, Carla; Abreu, Miguel Henriques; Richardson, Alan; Almeida, Raquel; Ricardo, Sara. "Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options". Cells (2024): https://doi.org/10.3390/cells13090786.
    10.3390/cells13090786
  7. Nunes, Mariana; Duarte, Diana; Vale, Nuno; Ricardo, Sara. "The antineoplastic effect of carboplatin is potentiated by combination with pitavastatin or metformin in a chemoresistant high-grade serous carcinoma cell line". International Journal of Molecular Sciences (2022): https://doi.org/10.3390/ijms24010097.
    10.3390/ijms24010097
  8. Duarte, Diana; Nunes, Mariana; Ricardo, Sara; Vale, Nuno. "Combination of antimalarial and CNS drugs with antineoplastic agents in MCF-7 breast and HT-29 colon cancer cells: biosafety evaluation and mechanism of action". Biomolecules 12 10 (2022): 1490-1490. http://dx.doi.org/10.3390/biom12101490.
    10.3390/biom12101490
  9. Nunes, Mariana; Duarte, Diana; Vale, Nuno; Ricardo, Sara. "Pitavastatin and ivermectin enhance the efficacy of paclitaxel in chemoresistant high-grade serous carcinoma". Cancers (2022): https://doi.org/10.3390/cancers14184357.
    10.3390/cancers14184357
  10. Magalhães, Ana C.; Ricardo, Sara; Moreira, Ana C. ; Nunes, Mariana; Tavares, Margarida ; Pinto, Ricardo J.; Gomes, Maria Salomé; Pereira, Luisa. "InfectionCMA: a cell microArray approach for efficient biomarker screening in in vitro infection assays". Pathogens (2022): https://doi.org/10.3390/pathogens11030313.
    10.3390/pathogens11030313
  11. Nunes, Mariana; Pacheco, Francisca; Coelho, Ricardo; Leitão, Dina; Ricardo, Sara; David, Leonor. "Mesothelin expression is not associated with the presence of cancer stem cell markers SOX2 and ALDH1 in ovarian cancer". International Journal of Molecular Sciences 23 3 (2022): 1016-1016. http://dx.doi.org/10.3390/ijms23031016.
    10.3390/ijms23031016
  12. Nunes, Mariana; Silva, Patrícia M. A.; Coelho, Ricardo; Pinto, Carla; Resende, Albina; Bousbaa, Hassan; Almeida, Gabriela M.; Ricardo, Sara. "Generation of two paclitaxel-resistant high-grade serous carcinoma cell lines with increased expression of P-glycoprotein". Frontiers in Oncology 11 (2021): http://dx.doi.org/10.3389/fonc.2021.752127.
    10.3389/fonc.2021.752127
  13. Nunes, Mariana; Henriques Abreu, Miguel; Bartosch, Carla; Ricardo, Sara. "Recycling the purpose of old drugs to treat ovarian cancer". International Journal of Molecular Sciences 21 20 (2020): 7768-7768. https://doi.org/10.3390/ijms21207768.
    10.3390/ijms21207768
  14. Coelho, Ricardo; Ricardo, Sara; Amaral, Ana Luísa; Huang, Yen-Lin; Nunes, Mariana; Neves, José Pedro; Mendes, Nuno; et al. "Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation". Oncogenesis 9 6 (2020): http://dx.doi.org/10.1038/s41389-020-00246-2.
    10.1038/s41389-020-00246-2
  15. Pinto, Cátia; Custódio, Valéria; Nunes, Mariana; Songy, Aurélie; Rabenoelina, Fanja; Courteaux, Barbara; Clément, Christophe; Gomes, Ana Catarina; Fontaine, Florence. "Understand the potential role of Aureobasidium pullulans, a resident microorganism from grapevine, to prevent the infection caused by Diplodia seriata". Frontiers in Microbiology 9 (2018): http://dx.doi.org/10.3389/fmicb.2018.03047.
    10.3389/fmicb.2018.03047
  16. Félix, Carina; Nunes, Mariana; Libório, Sofia; Félix, Rafael; Duarte, Ana Sofia; Alves, Artur; Esteves, Ana Cristina. "Lasiodiplodia theobromae as a producer of biotechnologically relevant enzymes". International Journal of Molecular Sciences 19 2 (2018): 29. http://dx.doi.org/10.3390/ijms19020029.
    10.3390/ijms19020029
Newspaper article
  1. Almeida-Nunes, Diana Luisa; Nunes, Mariana; Osorio, Hugo; Ferreira, Verónica; Lobo, Cláudia; Monteiro, Paula; Abreu, Miguel Henriques; et al. "Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression", Biochemistry and Biophysics Reports, 2024
Thesis / Dissertation
  1. "Drug Repurposing as a Strategy to Overcome Ovarian Cancer Chemoresistance". PhD, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2025. https://hdl.handle.net/10216/165587.
  2. Nunes, Mariana. "First line drug testing in ovarian cancer cell lines manipulated for Mesothelin expression". Master, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2019. https://repositorio-aberto.up.pt/handle/10216/122642.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2025/04/24 Development of Patient-Derived Cultures from Ovarian Cancer Malignant Ascites for Ex Vivo Drug Testing Seminar Series
Biomedical Sciences PhD program at CESPU (Gandra, Portugal)
2024/05/05 Ivermectin: an ally to reverse P-glycoprotein-associated multidrug resistance in ovarian cancer III 1H-TOXRUN INTERNATIONAL CONGRESS 2024 No Boundaries for Toxicology: One Health, One Society, One Planet THE BIG CHALLENGES FOR THE 21st CENTURY
TOXRUN (Porto, Portugal)
2019/05 First line drug testing in ovarian cancer cell lines manipulated for MSLN expression 2 nd Symposium Master Oncology
Instituto Português de Oncologia do Porto, Francisco Gentil, E.P.E. (Porto, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2023/01 - 2023/07 Evaluation of Chemoresistance Biomarkers in Ovarian Cancer Cell Lines
Co-supervisor
 Ciências Biomédicas (Degree)
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2022 - 2022 Phenotypic Evaluation of Ovarian Tumor cells Present in Malignant Ascites
Co-supervisor
 Ciências Biomédicas (Degree)
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2021/01 - 2021/07 Identification of Potential Biomarkers in Ascitic Fluid from Ovarian Cancer Patients
Co-supervisor
 Bioquímica (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2021/01 - 2021/07 Análise da Expressão da Glicoproteína-P em Recidivas de Tumores de Ovário
Co-supervisor
 Ciências Biomédicas (Degree)
Instituto Universitário de Ciências da Saúde, Portugal

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2025/07/03 - 2025/07/04 10º Curso Avançado Ginecologia Oncológica
Other
 10º Curso Avançado Ginecologia Oncológica
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2025/05/08 - 2025/05/09 IV 1H-TOXRUN INTERNATIONAL CONGRESS 2025 No Boundaries for Toxicology: One Health, One Society, One Planet EMPOWERING THE FUTURE GENERATIONS: THE SYNERGY OF SCIENCE, EDUCATION AND SOCIETY
Congress
 IV 1H-TOXRUN INTERNATIONAL CONGRESS 2025 No Boundaries for Toxicology: One Health, One Society, One Planet EMPOWERING THE FUTURE GENERATIONS: THE SYNERGY OF SCIENCE, EDUCATION AND SOCIETY
Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
2024/06/10 - 2024/06/13 EACR 2024 Congress: Innovative Cancer Science
Congress
 EACR 2024 Congress: Innovative Cancer Science
European Association For Cancer Research, United Kingdom
2024/05/23 - 2024/05/24 VII iBiMED Symposium: Sharing Science, Inspiring Progress
Symposium
 VII iBiMED Symposium: Sharing Science, Inspiring Progress
Universidade de Aveiro, Portugal
2024/05/09 - 2024/05/10 30th Porto Cancer Meeting: RNA Biology in Cancer
Meeting
 30th Porto Cancer Meeting: RNA Biology in Cancer
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2024/05/02 - 2024/05/02 III 1H-TOXRUN INTERNATIONAL CONGRESS 2024 No Boundaries for Toxicology: One Health, One Society, One Planet THE BIG CHALLENGES FOR THE 21st CENTURY
Congress
 III 1H-TOXRUN INTERNATIONAL CONGRESS 2024 No Boundaries for Toxicology: One Health, One Society, One Planet THE BIG CHALLENGES FOR THE 21st CENTURY
Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
2024/04/18 - 2024/04/19 10th McBiology Symposium
Symposium
 10th McBiology Symposium
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/11/22 - 2023/11/24 Congresso Nacional de Oncologia Congresso Nacional de Oncologia
Sociedade Portuguesa de Oncologia, Portugal
2023/11/16 - 2023/11/17 i3S Anual Meeting
Other
 i3S Anual Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/11/09 - 2023/11/09 1st Young Researchers' Day
Symposium
 1st Young Researchers' Day
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2023/10/03 - 2023/10/04 6th PhDay: Brilliant PhDs, brighter future: Shaping Science together!
Seminar
 Brilliant PhDs, brighter future: Shaping Science together!
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/04/27 - 2023/04/28 II TOXRUN International Congress 2023
Congress
 II TOXRUN International Congress 2023
Instituto Universitário de Ciências da Saúde Unidade de Investigação em Toxicologia, Portugal
2023/04/25 - 2023/04/26 EACR Conference: Stem Cell Biology, Cancer Plasticity and Therapeutic Potential, virtual event.
Conference
 Participation in EACR Conference: Stem Cell Biology, Cancer Plasticity and Therapeutic Potential, virtual event.
European Association For Cancer Research, United Kingdom
2022/12/07 - 2022/12/08 EACR Conference: The invisible phase of metastasis: Impact of dormancy, cancer cell plasticity and evolution of the niche during metastatic progression - Virtual Event
Conference
 EACR virtual conference on "The invisible phase of metastasis: Impact of dormancy, cancer cell plasticity and evolution of the niche during metastatic progression"
European Association For Cancer Research, United Kingdom
2022/11/11 - 2022/11/11 9th i3S Annual Meeting
Other
 9th i3S Annual Meeting
2022/06/30 - 2022/07/01 5th ASPIC International Congress
Congress
 5th ASPIC International Congress
ASPIC, Portugal
2022/04/07 - 2022/04/08 I Congresso Internacional da TOXRUN/ V Congresso da Associação Portuguesa de Ciências Forenses/XIV Jornadas Científicas de Ciências do Instituto Universitário de Ciências da Saúde
Congress
 I Congresso Internacional da TOXRUN/ V Congresso da Associação Portuguesa de Ciências Forenses/XIV Jornadas Científicas de Ciências do Instituto Universitário de Ciências da Saúde
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2022/01/25 - 2022/01/28 The Festival of Genomics & Biodata 2022 - Virtual Event
Conference
 The Festival of Genomics & Biodata 2022
Front Line Genomics, United Kingdom
2021/12/07 - 2021/12/08 EACR-AstraZeneca Virtual Conference: Drug Tolerant Persister Cells - Virtual Event
Conference
 EACR-AstraZeneca Virtual Conference: Drug Tolerant Persister Cells - Virtual Event
2021/10/14 - 2021/10/15 II ASPIC-ASEICA International Meeting: Current Trends in Precision Medicine in Cancer - Virtual Event
Meeting
 II ASPIC-ASEICA International Meeting: Current Trends in Precision Medicine in Cancer - Virtual Event
2021/10/05 - 2021/10/06 EACR Conference 2021: Goodbye Flat Biology: Next Generation Cancer Models - Virtual Event
Conference
 EACR Conference 2021: Goodbye Flat Biology: Next Generation Cancer Models - Virtual Event
European Association For Cancer Research, United Kingdom
2021/06/14 - 2021/06/18 XVII Congress of the Iberian Society of Cytometry - Virtual Edition
Congress
 XVII Congress of the Iberian Society of Cytometry - Virtual Edition
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2021/05/20 - 2021/05/21 27th Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation - Online Meeting
Meeting
 27th Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation - Online Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2021/05/03 - 2021/05/03 European Cancer Research Summit 2021 - Online Summit
Other
 European Cancer Research Summit 2021 - Online Summit
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2020/11/23 - 2020/11/23 Organoids With]Out[Borders - Online Symposium
Symposium
 Organoids With]Out[Borders - Online Symposium
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2020/10/09 - 2020/10/10 Molecular Analysis for Precision Oncology - Virtual Congress
Congress
 Molecular Analysis for Precision Oncology - Virtual Congress
European Society for Medical Oncology, Switzerland
2019/12/13 - 2019/12/13 1st DevBioMed Symposium - From Developmental Biology to Medicine and Back
Symposium
 1st DevBioMed Symposium - From Developmental Biology to Medicine and Back
Fundação Champalimaud, Portugal
2019/09/24 - 2019/09/24 1º Encontro Nacional de Jovens Investigadores em Oncologia
Meeting
 1º Encontro Nacional de Jovens Investigadores em Oncologia
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2019/06/27 - 2019/06/28 Biointerface - 7th Advanced Summer School - Do Organoids Fill the In Vitro/In Vivo Gap?
Other
 Biointerface - 7th Advanced Summer School - Do Organoids Fill the In Vitro/In Vivo Gap?
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2019/04/15 - 2019/04/16 3nd Symposium Master Oncology
Symposium
 3nd Symposium Master Oncology
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2018/11/29 - 2018/11/30 7th i3S Annual Meeting - Interfaces
Other
 7th i3S Annual Meeting - Interfaces
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2018/05/07 - 2018/05/08 2nd Symposium Master Oncology
Symposium
 2nd Symposium Master Oncology
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2018/04/18 - 2018/04/18 Imuno-Oncologia - Tratamentos inovadores
Conference
 Imuno-Oncologia - Tratamentos inovadores
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal

Ad Hoc journal article review

Journal title (ISSN) Publisher
2026/01 - Current Discover Oncology Springer Nature
2026/01 - Current BMC Cancer Springer Nature
2026/01 - Current Frontiers in Oncology Frontiers
2025/11/07 - Current Current Oncology (ISSN 1718-7729) MDPI
2025/09/25 - Current IJMS (ISSN 1422-0067) MDPI
2025/09/15 - Current Biomolecules (ISSN 2218-273X) MDPI

Other jury / evaluation

Activity description Institution / Organization
2025/07 - Current Examiner of the internship report for the Research Project course of the Bachelor's Degree in Biomedical Sciences, entitled “Investigating the Antitumor and Antimitotic Effects of Chalcone Derivatives in Cancer Cell Lines.” Cooperativa de Ensino Superior Politécnico e Universitário CRL, Portugal
2025/06/23 - Current Prova de Seminário do Doutoramento em Ciências Farmacêuticas da estudante Inês Nunes Ribeiro da Mota na Faculdade de Farmácia da Universidade do Porto Universidade do Porto Faculdade de Farmácia, Portugal
Distinctions

Award

2025 Prémio de Comunicação com Maior Relevância Social: "Construção de “Cell Microarrays” como Estratégia para Avaliar Alterações na Expressão de Proteínas Induzidas por Tratamento em Linhas Celulares de Cancro do Ovário"
Instituto Politécnico de Bragança Escola Superior de Hotelaria e Bem-Estar, Portugal
2025 Prémio de Melhor Poster: “Perfil de exaustão de células T na ascite de carcinoma seroso de alto grau: um marcador de mau prognóstico” - 10º Curso Avançado Ginecologia Oncológica
Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Portugal
2022 Best Poster Award - Combining Paclitaxel With Repurposing Drugs Improve Ovarian Cancer Management - APCF Associação Portuguesa Ciênicas Forenses
APCF Associação Portuguesa Ciências Forenses, Portugal

Other distinction

2022 EACR-Worldwide Cancer Research Meeting Bursary - The invisible phase of metastasis: Impact of dormancy, cancer cell plasticity and evolution of the niche during metastatic progression - Virtual Event
European Association For Cancer Research, United Kingdom